CH

Commerce Health Ventures

North America, Pennsylvania, United States, Radnor

Description

Investments in health care and pharmaceutical industries with a focus on biopharmaceutical, medical devices.

Investor Profile

Commerce Health Ventures has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Series B (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Health Diagnostics
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Commerce Health Ventures frequently co-invest with?

GP
Europe, Ankara, Turkey, Ankara
Co-Investments: 1
Seaflower Ventures
North America, Massachusetts, United States, Waltham
Co-Investments: 1
Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 1
NewSpring Ventures
North America, Pennsylvania, United States, Radnor
Co-Investments: 2
Sprout Group
North America, New York, United States, New York
Co-Investments: 1
HealthCap
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
ProQuest
North America, Michigan, United States, Ann Arbor
Co-Investments: 1
TL Ventures
North America, Pennsylvania, United States, Wayne
Co-Investments: 1
EE
North America, New Jersey, United States, Bedminster
Co-Investments: 1

What are some of recent deals done by Commerce Health Ventures?

EKR Therapeutics

Bedminster, New Jersey, United States

EKR Therapeutics provides a segment of the healthcare market with products to improve patient outcomes and quality of life.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series BJul 3, 2006
Amount Raised: $5,000,000
Sopherion Therapeutics

East Brunswick, New Jersey, United States

Sopherion has the US and Canadian rights to this liposomal nanotechnology that targets the tumor vasculature.

BiotechnologyHealth CareHealth DiagnosticsPharmaceutical
Series BSep 20, 2004
Amount Raised: $47,000,000